Completed PHASE1 INTERVENTIONAL 1-arm NCT04134676

Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds

Therapeutic Potential of Stem Cell Conditioned Medium on Chronic Ulcer Wounds : Pilot Study in Human

Sponsor: PT Pharma Metric Labs

Updated 6 times since 2019 Last updated: Jun 18, 2020 Started: Jun 1, 2019 Primary completion: May 10, 2020 Completion: Jun 10, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Chronic Ulcer, this trial is completed. The trial is conducted by PT Pharma Metric Labs and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE1
Jul 2024 — Sep 2024 [monthly]

Completed PHASE1
Oct 2021 — Jul 2024 [monthly]

Completed PHASE1
Jan 2021 — Oct 2021 [monthly]

Completed PHASE1
Jul 2020 — Jan 2021 [monthly]

Completed PHASE1

Status: Not Yet Recruiting → Completed

▶ Show 1 earlier version

Nov 2019 — Jul 2020 [monthly]

Not Yet Recruiting PHASE1

First recorded

Jun 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

PT Pharma Metric Labs
Stem Cell and Cancer Institute, Kalbe Farma Tbk
Sukma Skin Treatment

Data source: Sukma Skin Treatment

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Tangerang, Indonesia